Nu Skin Enterprises (NYSE:NUS) Updates Q4 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.68-0.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. The company issued revenue guidance of $570-590 million, compared to the consensus revenue estimate of $642.26 million.

A number of research analysts have weighed in on NUS shares. Citigroup cut shares of Nu Skin Enterprises from a buy rating to a neutral rating in a research note on Wednesday. DA Davidson set a $42.00 target price on shares of Nu Skin Enterprises and gave the company a hold rating in a research note on Friday, October 11th. Pivotal Research reiterated a buy rating and issued a $70.00 target price on shares of Nu Skin Enterprises in a research note on Wednesday, August 7th. Zacks Investment Research cut shares of Nu Skin Enterprises from a strong-buy rating to a hold rating and set a $52.00 target price on the stock. in a research note on Thursday, October 24th. Finally, ValuEngine upgraded shares of Nu Skin Enterprises from a sell rating to a hold rating in a research note on Wednesday, October 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $51.63.

Shares of NYSE NUS traded up $0.78 during midday trading on Friday, hitting $41.29. The company’s stock had a trading volume of 7,078 shares, compared to its average volume of 333,862. The stock has a fifty day moving average price of $42.92 and a 200 day moving average price of $45.35. Nu Skin Enterprises has a one year low of $35.03 and a one year high of $70.26. The company has a current ratio of 1.90, a quick ratio of 1.20 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $2.57 billion, a price-to-earnings ratio of 11.71, a P/E/G ratio of 1.54 and a beta of 0.75.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.03. Nu Skin Enterprises had a net margin of 4.59% and a return on equity of 23.79%. The company had revenue of $590.00 million for the quarter, compared to analyst estimates of $605.02 million. During the same quarter in the previous year, the firm posted $0.94 earnings per share. The company’s quarterly revenue was down 13.9% compared to the same quarter last year. On average, equities research analysts predict that Nu Skin Enterprises will post 3.11 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be given a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 3.58%. The ex-dividend date is Wednesday, November 27th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 42.05%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Further Reading: No Load Funds

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.